CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Net sales	$ 3,965	$ 3,922	$ 4,231
Cost of products sold	1,879	1,795	1,884
Gross profit	2,086	2,127	2,347
Selling, general, and administrative expenses	1,613	1,589	1,551
Research and development expenses	184	174	171
Goodwill and intangible asset impairments	307	1,287	0
Restructuring and other costs	67	14	17
Operating (loss) income	(85)	(937)	608
Other income and expenses:
Interest expense, net	81	65	61
Other expense (income), net	9	53	2
(Loss) income before income taxes	(175)	(1,055)	545
(Benefit) provision for income taxes	(43)	(105)	134
Net (loss) income	(132)	(950)	411
Less: Net income (loss) attributable to noncontrolling interests	0	0	0
Net (loss) income attributable to Dentsply Sirona	$ (132)	$ (950)	$ 411
Net (loss) income per common share attributable to Dentsply Sirona:
Basic (in dollars per share)	$ (0.62)	$ (4.41)	$ 1.88
Diluted (in dollars per share)	$ (0.62)	$ (4.41)	$ 1.87
Weighted average common shares outstanding:
Basic (in shares)	212.0	215.5	218.4
Diluted (in shares)	212.0	215.5	220.2